Engineering of an ω-3 polyunsaturated fatty acid-containing nanoemulsion system for combination C6-ceramide and 17β-estradiol delivery and bioactivity in human …

D Deshpande, DR Janero, M Amiji - … : Nanotechnology, Biology and …, 2013 - Elsevier
Delayed endothelial cell (EC) regeneration and the medial vascular smooth muscle cells
(VSMCs) proliferation contribute to arterial restenosis. Although ω-3-polyunsaturated fatty …

Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface

AK Mahapatra, PN Murthy, S Samoju… - Critical Reviews™ in …, 2014 - dl.begellhouse.com
Nanoscale materials with a broad spectrum of applications are providing a new foundation
for technological integration and innovation. In this article, we review various polymers being …

[PDF][PDF] Nanomedicine for the diagnosis and treatment of cardiovascular disease: current status and future perspective

E Gundogdu, Z Senyigit, D Ilem-Ozdemir - Cardiovascr Dis I, 2014 - academia.edu
Cardiovascular disease (CVD) encompasses all pathologies of the heart or circulatory
system, including coronary heart disease, peripheral vascular disease and stroke …

Preparation and characterization of radiolabeled magnetic nanoparticles as an imaging agent

Ç İçhedef, S Teksöz, P Ünak, EI Medine, T Ertay… - Journal of Nanoparticle …, 2012 - Springer
Magnetic nanoparticles were prepared by a reduction–precipitation method and coated with
an amino silane coupling agent. Guanine (Gua) was conjugated to the magnetic …

Development of antithrombotic nanoconjugate blocking integrin α2β1-collagen interactions

C Zhang, L Zhang, Y Zhang, N Sun, S Jiang… - Scientific Reports, 2016 - nature.com
An antithrombotic nanoconjugate was designed in which a designed biomimetic peptide
LWWNSYY was immobilized to the surface of poly (glycidyl methacrylate) nanoparticles …

Nanomedicine highlights in atherosclerosis

V Karagkiozaki - Journal of nanoparticle research, 2013 - Springer
Atherosclerosis is a multifactorial disease and many different approaches have been
attempted for its accurate diagnosis and treatment. The disease is induced by a low-grade …

Targeted drug delivery for cardiovascular and Cerebrovascular Diseases

J Luan, G Zhai - Current Drug Targets, 2016 - ingentaconnect.com
Cardiovascular and cerebrovascular diseases (CCVD) are a major and increasing health
burden worldwide. Although treatments have been made a certain progress, the …

Comparison of three different conjugation strategies in the construction of herceptin-bearing paclitaxel-loaded nanoparticles

K Yu, Y Zhou, Y Li, X Sun, F Sun, X Wang, H Mu… - Biomaterials …, 2016 - pubs.rsc.org
Research on quantitatively controlling the ligand density on the surface of nanocarriers is in
the frontier and becomes a technical difficulty for targeted delivery system designing. In this …

Emerging use of nanoparticles in diagnosis of atherosclerosis disease: A review

F De Sarno, AM Ponsiglione, E Torino - AIP Conference Proceedings, 2018 - pubs.aip.org
Despite over the last decades, cardiovascular research has significantly enhanced our
understanding of the atherosclerotic process, the molecular mechanisms underlying the …

[HTML][HTML] 补片材料在心血管手术中的应用进展

邵茹冰, 李杰华, 王伦常, 李鑫, 舒畅 - Journal of Central South …, 2023 - ncbi.nlm.nih.gov
心血管补片作为替代部分心脏或血管组织的人工移植物材料, 在心血管手术中起至关重要的
作用。 传统的心血管补片材料(合成材料和生物材料等) 的不足可能导致术后长期效果不理想 …